JBS acquires European company to expand its global plant-based food platform
Purchase of Vivera, Europe’s third-largest plant-based protein producer for €341 million includes three manufacturing facilities and a research center in the Netherlands
JBS, the world’s largest protein company and second-largest food producer, has entered into an agreement to purchase Vivera, Europe’s third-largest plant-based food company, for an enterprise value of €341 million. Vivera develops and produces a broad range of innovative plant-based meat replacement products for major retailers in over 25 countries across Europe, with relevant market share in the Netherlands, the United Kingdom and Germany. The deal includes three manufacturing facilities and a research and development center located in the Netherlands.
JBS acquires European company to expand its global plant-based food platform
JBS
The acquisition of Vivera strengthens and boosts JBS’ global plant-based food platform. Strong growth is expected in this category throughout global markets. The deal will add a brand to JBS’ portfolio that is well- established in consumer preference, strengthening the Company’s focus on value-added products.
Vivera, currently the largest independent plant-based company in Europe, will join other JBS initiatives such as Seara’s Incrível line, a market leader in plant-based hamburgers in Brazil, and Planterra, with the OZO brand in the United States.
“This acquisition is an important step to strengthen our global plant-based protein platform,” said Gilberto Tomazoni, global CEO, JBS. “Vivera will give JBS a stronghold in the plant-based sector, with technological knowledge and capacity for innovation.”
To nurture its entrepreneurial spirit, JBS plans to manage Vivera as a standalone business unit with its current leadership team to remain in place.
“Joining forces with JBS gives us access to significant resources and capabilities to accelerate our current strong growth trajectory and Vivera brand expansion,” said Willem van Weede, CEO, Vivera.
The deal was approved by the JBS board of directors and will be concluded after approval by antitrust authorities.
Other news from the department business & finance
